EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS088-03688 
Organism
Homo sapiens 
Tissue/cell
HeLa-S3 
Coordinate
chr1:153656300-153657430 
Target genes
TF binding sites/motifs
Number: 4             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
IRF1MA0050.2chr1:153656852-153656873TCTTTCTTTCTTTTTTTTTTT+6.25
Nr2f6(var.2)MA0728.1chr1:153657086-153657101CGATCTCTTGACCTC-6
ZNF263MA0528.1chr1:153656779-153656800CAAGGAGGGAGGGGAGAAAAA+6.09
ZNF263MA0528.1chr1:153656451-153656472AGAGGAGAAAGAAAGAGAAGG+6.21
Number of super-enhancer constituents: 3             
IDCoordinateTissue/cell
SE_00751chr1:153655073-153656909Adipose_Nuclei
SE_02172chr1:153655647-153656913Aorta
SE_02172chr1:153657053-153658952Aorta
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr1153656514153656656
Number: 2             
IDChromosomeStartEnd
GH01I153682chr1153655074153656913
GH01I153684chr1153657054153662295
Enhancer Sequence
GTGAGCTGTG ATGTGGGGGG TTGAGTGAGG CTGGGGGACC CGGAGAACCA ATAGCAGAGG 60
AGGCGGTGGG GACCCAGAGG GAAGAGGGCA GGGGTGAAGG GGCACCAGGG GAAAACCAAG 120
GGAGATGAGG AAGAAAGGAG GCTTAAAAGC CAGAGGAGAA AGAAAGAGAA GGGAATGGCA 180
GGGCGAGGGG AGGAGACAAG GATAGGAATG GCCAAGGAGA GTCAGAAAGA TCCAAGAAGC 240
AGAGAAGTTG ATGGGTGACA TCATAGGGGC GTGGACTGGT TTTCCTTGCT ACTCTTGCAG 300
GCCAGATAGG AAGCAACTTT CTGAACCTTT GCAATCATGC CCATGTTAGC TGAGGAGGGT 360
GAGCCCTGGT GTGTGCCAGG TGCCCAACCT AGAATGGAGA AGGGAGCTGA ATGAGCCTTG 420
TTCCTGCCGT CCAGTGGAGG CTAAAATGAA GTACAGGAGG AGTTAATGAT ATACAAAAGC 480
AAGGAGGGAG GGGAGAAAAA TCACTGCTGG TTGAGCATAT AATGTGTGCC AGGCACTTCC 540
ACGTACACTA TTTCTTTCTT TCTTTTTTTT TTTTTTTTTT TTTTTTGAGA CGGAGTCTCG 600
CTCTGTTGCC AGACTGGAGT GCAGTGGCAT GATCTAGGCT CACTGCAACC TCCGCCTCCC 660
AGTTTCAAGC AATTCTCCTG CCTCAGCCTC CCATGTAGCT GGGACTACAG GCACATGCCA 720
CCACGCTCAG CTAATTTTTG TATTTTTAGT AGAGACAGGG TTTCACCATG TTGGCCAGGA 780
TGGTCTCGAT CTCTTGACCT CATGATCCAC CCACCTTGGC CTCCCAAAGT GCTGGGATTA 840
CAGGCATGAG CCACTGTGCC TGGCCTCATG TTCACTATTT CTTTTCATTC TTATAATAGT 900
TAAGAATGAA ATAGATATTG CGGCCTCATT CCCAAGTAAG GACATTGAGG TGATTCCCCC 960
AAGGTCCCCA GTAAGGCAGA ATTTCCCCCA GCCATCCTGA TTCTCAGTCC AGAGGATAGA 1020
ATTCCCCCTC CATCTCTGAG TGCATGGTGT GGTCCCACGG CTCTGAGGAG GGGCTGCTGA 1080
GCACCCTGCC CTGGGTCAGC GGCTCAGCCA CAGGCTCAGA TGCAGCCTTC 1130